These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 35676614

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pediatric SJS-TEN: Where are we now?
    Ramien M, Goldman JL.
    F1000Res; 2020; 9():. PubMed ID: 32850118
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T, French LE.
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Undiagnosed and Rare Diseases in Critical Care: Severe Mucocutaneous Medication Reactions.
    Shields BE, Wanat KA, Chiu YE.
    Crit Care Clin; 2022 Apr; 38(2):243-269. PubMed ID: 35369946
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapy.
    Heuer R, Paulmann M, Annecke T, Behr B, Boch K, Boos AM, Brockow K, French LE, Gille J, Gundlach V, Hartmann B, Höger P, Hofmann SC, Klein T, Lehnhardt M, Liß Y, Maier P, Mandel P, Marathovouniotis N, Marlok F, Mittelviefhaus H, Pleyer U, Pradeau M, Rall K, Rieg S, Rittner H, Sander F, Schnitzler S, Schut C, Stolle A, Vorobyev A, Wedi B, Weiss J, Zepp M, Ziemer M, Mockenhaupt M, Nast A.
    J Dtsch Dermatol Ges; 2024 Oct; 22(10):1448-1466. PubMed ID: 39314017
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Severe drug-induced skin reactions. Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Mockenhaupt M.
    Hautarzt; 2014 May; 65(5):415-23. PubMed ID: 24820799
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N, Elmrahi A, Dikhaye S, Fihmi N, Alami Z.
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [Abstract] [Full Text] [Related]

  • 19. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review.
    Al Rajaibi R, Al Rumhi T, Al Abri AM.
    Sultan Qaboos Univ Med J; 2021 Aug; 21(3):491-494. PubMed ID: 34522420
    [Abstract] [Full Text] [Related]

  • 20. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM, Do A, Berger TG, Nguyen AH, DeWeese J, Malone JD, Jordan K, Hom F, Tuffanelli L, Fillari P, Siu S, Grossman R.
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.